I’m excited to share a deeper look into my professional journey and the experiences that have shaped my career across global biopharma, commercialization, and leadership. It has been an incredible path building markets, launching transformative therapies, and working alongside inspiring teams worldwide. Here is my biography.

Lynn Cinelli is a globally respected healthcare and supply chain executive whose career spans over two decades of transformative leadership across biopharma operations, policy, and public health strategy. She currently leads global biologics supply at Bristol Myers Squibb, overseeing more than \$20 billion in annual revenue and pioneering digital and operational advancements that enhance product delivery and resilience. With a foundation in biological engineering and a proven track record at Merck in vaccines, policy, and global access, Lynn has consistently delivered strategic outcomes in complex, multinational environments. She is also a recognized champion of diversity and inclusion, an active board advisor, and a thought leader committed to building sustainable, high-performing systems that improve health outcomes worldwide.

Arup Pramanik is a globally recognized healthcare executive who has spent 25 years transforming how innovation reaches patients. With deep expertise in market access, pricing strategy, and digital health, Arup has led major global initiatives across top pharmaceutical companies including Boehringer Ingelheim, Novartis, and Takeda. Known for uniting science with strategy, he has reshaped commercialization pathways through AI, real-world evidence, and value-based models—delivering outcomes that benefit both enterprise growth and health equity. Now preparing for board roles, Arup brings unmatched global insight, cross-sector leadership, and a bold vision for patient-centered innovation.

Miguel Nogueras is a globally recognized executive leader in microbiological quality and sterility assurance, known for driving innovation, regulatory excellence, and inclusive leadership across the pharmaceutical, medical device, and consumer health industries. With more than two decades of experience, he has built and led high-performing global teams, established end-to-end quality systems, and introduced advanced contamination control strategies that ensure patient safety and accelerate product delivery. Fluent in multiple languages and deeply committed to mentorship and diversity, Miguel blends scientific expertise with business acumen to deliver sustainable, compliant, and forward-thinking solutions in dynamic global markets.

Susan Essumang is a seasoned clinical operations executive who merges scientific rigor with strategic leadership to drive high-impact pharmaceutical and biotech programs. Known for her patient-centric approach, Susan has led the development and regulatory success of globally recognized treatments, including Victoza®, Ozempic®, and Wegovy®, delivering billions in projected revenue. Her ability to align enterprise objectives with operational excellence has resulted in accelerated trial timelines, significant cost savings, and flawless regulatory inspections. With deep therapeutic expertise, a foundation in neuroscience and healthcare administration, and a commitment to innovation, Susan continues to shape the future of clinical research through data-driven insights and strategic execution.

Walt Johnston is a seasoned pharmaceutical executive known for driving transformative growth across global commercial operations, with a proven ability to launch and scale flagship brands in competitive therapeutic markets. His leadership spans over 30 years at industry powerhouses such as Pfizer, Astellas, Urovant Sciences, and Sumitomo Pharma, where he has consistently delivered above-market performance, integrated complex portfolios, and cultivated award-winning teams. With a deep commitment to integrity, collaboration, and innovation, Walt excels at aligning cross-functional strategy, optimizing organizational capability, and engaging stakeholders at every level—from boardrooms to the frontlines.

Omar Kassim is a globally respected executive in pharmaceutical development and supply chain strategy, known for his leadership in CDMO partnership management, external manufacturing, and complex contract negotiations. With over two decades of experience spanning finance, procurement, and technical operations, he has guided multinational teams through end-to-end product development, from pre-clinical research to commercial launch. Currently leading Takeda’s Pharmaceutical Sciences CDMO organization, Omar drives strategic network design, vendor governance, and asset integration across 175 global partners. His deep expertise in combination products and drug delivery systems, coupled with a strong foundation in finance and biochemistry, positions him as a key architect of cross-functional success in today’s evolving life sciences landscape.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

Rudy Pearce is a seasoned pharmaceutical executive with a proven track record in managed markets, government accounts, and sales leadership. With over three decades of experience, he has successfully led teams, negotiated high-impact contracts, and expanded market access for critical therapies. His expertise spans commercial and government healthcare sectors, where he has driven formulary wins, launched new products, and strengthened partnerships across PBMs, Medicare, Medicaid, and the Department of Defense. Recognized nationally for his leadership and strategic vision, Rudy is a results-driven professional dedicated to enhancing healthcare access and driving organizational success.